Published in Am J Pathol on May 01, 2004
Discoidin domain receptor tyrosine kinases: new players in cancer progression. Cancer Metastasis Rev (2012) 1.96
The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis. Nat Cell Biol (2013) 1.93
Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis Tissue Repair (2012) 1.65
Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma. Br J Cancer (2007) 1.53
Modulation of cell migration and invasiveness by tumor suppressor TSC2 in lymphangioleiomyomatosis. Am J Respir Cell Mol Biol (2005) 1.30
Discoidin domain receptor functions in physiological and pathological conditions. Int Rev Cell Mol Biol (2014) 1.29
Discoidin domain receptors: unique receptor tyrosine kinases in collagen-mediated signaling. J Biol Chem (2013) 1.27
Structural basis of the collagen-binding mode of discoidin domain receptor 2. EMBO J (2007) 1.26
The bladder extracellular matrix. Part I: architecture, development and disease. Nat Rev Urol (2009) 1.19
Rapamycin-insensitive up-regulation of MMP2 and other genes in tuberous sclerosis complex 2-deficient lymphangioleiomyomatosis-like cells. Am J Respir Cell Mol Biol (2009) 1.15
A novel dwarfism with gonadal dysfunction due to loss-of-function allele of the collagen receptor gene, Ddr2, in the mouse. Mol Endocrinol (2008) 1.13
Mapping of DDR1 distribution and oligomerization on the cell surface by FRET microscopy. J Mol Biol (2008) 1.07
mTOR activation, lymphangiogenesis, and estrogen-mediated cell survival: the "perfect storm" of pro-metastatic factors in LAM pathogenesis. Lymphat Res Biol (2010) 1.05
Discoidin domain receptor 2 mediates tumor cell cycle arrest induced by fibrillar collagen. J Biol Chem (2005) 1.04
Identification of disulfide-linked dimers of the receptor tyrosine kinase DDR1. J Biol Chem (2007) 1.00
Mammalian target of rapamycin signaling and autophagy: roles in lymphangioleiomyomatosis therapy. Proc Am Thorac Soc (2010) 0.99
RNA-Seq profiling reveals novel hepatic gene expression pattern in aflatoxin B1 treated rats. PLoS One (2013) 0.97
Inhibition of collagen fibrillogenesis by cells expressing soluble extracellular domains of DDR1 and DDR2. J Mol Biol (2009) 0.94
Collagen I induces discoidin domain receptor (DDR) 1 expression through DDR2 and a JAK2-ERK1/2-mediated mechanism in primary human lung fibroblasts. J Biol Chem (2011) 0.93
Myocardial fibroblast-matrix interactions and potential therapeutic targets. J Mol Cell Cardiol (2014) 0.91
Discoidin domain receptors regulate the migration of primary human lung fibroblasts through collagen matrices. Fibrogenesis Tissue Repair (2012) 0.90
Discoidin domain receptor-1 deficiency attenuates atherosclerotic calcification and smooth muscle cell-mediated mineralization. Am J Pathol (2009) 0.89
Regulation of collagen fibrillogenesis by cell-surface expression of kinase dead DDR2. J Mol Biol (2008) 0.86
Loss of discoidin domain receptor 2 promotes hepatic fibrosis after chronic carbon tetrachloride through altered paracrine interactions between hepatic stellate cells and liver-associated macrophages. Am J Pathol (2011) 0.86
Tyrosyl phosphorylated serine-threonine kinase PAK1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion. Adv Exp Med Biol (2015) 0.83
High expression of DDR1 is associated with the poor prognosis in Chinese patients with pancreatic ductal adenocarcinoma. J Exp Clin Cancer Res (2015) 0.82
Transcriptome analysis reveals an unexpected role of a collagen tyrosine kinase receptor gene, Ddr2, as a regulator of ovarian function. Physiol Genomics (2009) 0.81
Direct quantification of gene expression using capillary electrophoresis with laser-induced fluorescence. Anal Biochem (2006) 0.78
The Action of Discoidin Domain Receptor 2 in Basal Tumor Cells and Stromal Cancer-Associated Fibroblasts Is Critical for Breast Cancer Metastasis. Cell Rep (2016) 0.78
Circulating fibrocytes as predictors of adverse events in unstable angina. Transl Res (2016) 0.78
Discoidin domain receptor 2 germline gene deletion leads to altered heart structure and function in the mouse. Am J Physiol Heart Circ Physiol (2014) 0.78
High shear stress induces atherosclerotic vulnerable plaque formation through angiogenesis. Regen Biomater (2016) 0.78
Fetal hypoxia and programming of matrix metalloproteinases. Drug Discov Today (2011) 0.77
Evaluation of discoidin domain receptor-2 (DDR2) expression level in normal, benign, and malignant human prostate tissues. Res Pharm Sci (2015) 0.77
Discoidin Domain Receptor-1 Regulates Calcific Extracellular Vesicle Release in Vascular Smooth Muscle Cell Fibrocalcific Response via Transforming Growth Factor-β Signaling. Arterioscler Thromb Vasc Biol (2016) 0.77
Discoidin domain receptor-1 and periostin: new players in chronic kidney disease. Nephrol Dial Transplant (2015) 0.76
Collagen Fibril Ultrastructure in Mice Lacking Discoidin Domain Receptor 1. Microsc Microanal (2016) 0.76
Atherosclerosis--an inflammatory disease. N Engl J Med (1999) 59.28
Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes. Proc Natl Acad Sci U S A (1977) 40.24
Integrins: bidirectional, allosteric signaling machines. Cell (2002) 36.25
Integrins: versatility, modulation, and signaling in cell adhesion. Cell (1992) 34.06
The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (1993) 27.07
How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol (2001) 14.05
Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest (1994) 7.25
Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM). J Biol Chem (2002) 4.19
The discoidin domain receptor tyrosine kinases are activated by collagen. Mol Cell (1997) 4.11
An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Mol Cell (1997) 2.89
Construction and analysis of a human-chimpanzee comparative clone map. Science (2002) 2.83
Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation (1999) 2.73
Divergence between samples of chimpanzee and human DNA sequences is 5%, counting indels. Proc Natl Acad Sci U S A (2002) 2.57
Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell (1996) 2.55
Immunocytochemical analysis of cellular components in atherosclerotic lesions. Use of monoclonal antibodies with the Watanabe and fat-fed rabbit. Arteriosclerosis (1986) 2.27
Discoidin domain receptors: structural relations and functional implications. FASEB J (1999) 2.23
Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development. Mol Cell Biol (2001) 2.01
Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res (2002) 1.98
Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest (1994) 1.97
DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. J Clin Invest (2001) 1.89
Role of elastic fiber degradation in emphysema-like lesions of pulmonary lymphangiomyomatosis. Hum Pathol (1990) 1.85
Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by alpha 1 beta 1 and alpha 2 beta 1 integrins. J Cell Biol (1995) 1.82
The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism. EMBO Rep (2001) 1.76
Factors involved in the regulation of type I collagen gene expression: implication in fibrosis. Exp Biol Med (Maywood) (2002) 1.70
Degraded collagen fragments promote rapid disassembly of smooth muscle focal adhesions that correlates with cleavage of pp125(FAK), paxillin, and talin. J Cell Biol (1999) 1.70
Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessation model. Circulation (2000) 1.61
Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM). Hum Pathol (1997) 1.53
Discoidin domain receptor 2 regulates fibroblast proliferation and migration through the extracellular matrix in association with transcriptional activation of matrix metalloproteinase-2. J Biol Chem (2001) 1.51
Absence of integrin alpha1beta1 in the mouse causes loss of feedback regulation of collagen synthesis in normal and wounded dermis. J Cell Sci (1999) 1.43
Dynamic expression of alpha 1 beta 1 and alpha 2 beta 1 integrin receptors by human vascular smooth muscle cells. Alpha 2 beta 1 integrin is required for chemotaxis across type I collagen-coated membranes. Am J Pathol (1994) 1.38
Collagens in atherosclerosis. Coll Relat Res (1985) 1.36
Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. J Vasc Surg (1994) 1.35
Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features. J Nippon Med Sch (2000) 1.27
Tyrosine kinase activity of discoidin domain receptor 1 is necessary for smooth muscle cell migration and matrix metalloproteinase expression. Circ Res (2002) 1.25
The discoidin domain receptor tyrosine kinase DDR1 in arterial wound repair. J Clin Invest (2001) 1.25
The distribution of collagen types I, III and V (AB) in normal and atherosclerotic human aorta. J Pathol (1980) 1.15
Efficient expression of exogenous genes in primary vascular cells using IRES-based retroviral vectors. Biotechniques (2002) 1.11
A three-dimensional collagen lattice activates NF-kappaB in human fibroblasts: role in integrin alpha2 gene expression and tissue remodeling. J Cell Biol (1998) 1.09
Identification of two novel, kinase-deficient variants of discoidin domain receptor 1: differential expression in human colon cancer cell lines. FASEB J (2001) 1.02
Upregulation of basement membrane-degrading metalloproteinase secretion after balloon injury of pig carotid arteries. Circ Res (1996) 1.00
Ligand-induced shedding of discoidin domain receptor 1. FEBS Lett (2002) 0.92
p38 mitogen-activated kinase is a bidirectional regulator of human fibroblast collagenase-1 induction by three-dimensional collagen lattices. Biochem J (2001) 0.87
Pathophysiology and inflammatory aspects of plaque rupture. Cardiol Clin (1996) 0.85
Control of type I collagen formation in the lung. Am J Physiol (1991) 0.81
The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer (2005) 5.57
Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ Res (2007) 4.92
EGF receptor is required for KRAS-induced pancreatic tumorigenesis. Cancer Cell (2012) 3.19
Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKbeta. Arterioscler Thromb Vasc Biol (2005) 3.01
Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest (2005) 2.44
v-Src's hold over actin and cell adhesions. Nat Rev Mol Cell Biol (2002) 2.40
Smooth muscle cell plasticity: fact or fiction? Circ Res (2012) 2.18
The calpain system and cancer. Nat Rev Cancer (2011) 2.10
Emerging roles for ectodomain shedding in the regulation of inflammatory responses. J Leukoc Biol (2006) 1.77
A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16. J Immunol (2004) 1.64
Fibrillar collagen regulation of plasminogen activator inhibitor-1 is involved in altered smooth muscle cell migration. Arterioscler Thromb Vasc Biol (2002) 1.52
Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17). J Biol Chem (2003) 1.50
Inhibition of calpain stabilises podosomes and impairs dendritic cell motility. J Cell Sci (2006) 1.47
Spatial regulation of RhoA activity during pancreatic cancer cell invasion driven by mutant p53. Cancer Res (2011) 1.44
Real-time study of E-cadherin and membrane dynamics in living animals: implications for disease modeling and drug development. Cancer Res (2009) 1.25
ADAM10 mediates ectodomain shedding of the betacellulin precursor activated by p-aminophenylmercuric acetate and extracellular calcium influx. J Biol Chem (2004) 1.22
Gene therapy of apolipoprotein E-deficient mice using a novel macrophage-specific retroviral vector. Blood (2002) 1.19
Comparison of methods for image-based profiling of cellular morphological responses to small-molecule treatment. J Biomol Screen (2013) 1.19
Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival. Proc Natl Acad Sci U S A (2013) 1.16
Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice. Am J Pathol (2002) 1.15
High-content phenotypic profiling of drug response signatures across distinct cancer cells. Mol Cancer Ther (2010) 1.13
AP-1 differentially expressed proteins Krp1 and fibronectin cooperatively enhance Rho-ROCK-independent mesenchymal invasion by altering the function, localization, and activity of nondifferentially expressed proteins. Mol Cell Biol (2006) 1.12
Activation of IKKbeta by glucose is necessary and sufficient to impair insulin signaling and nitric oxide production in endothelial cells. J Mol Cell Cardiol (2005) 1.11
Efficient expression of exogenous genes in primary vascular cells using IRES-based retroviral vectors. Biotechniques (2002) 1.11
Inhibition of PDGF-stimulated and matrix-mediated proliferation of human vascular smooth muscle cells by SPARC is independent of changes in cell shape or cyclin-dependent kinase inhibitors. J Cell Biochem (2002) 1.08
MMP-9 sheds the beta2 integrin subunit (CD18) from macrophages. Mol Cell Proteomics (2008) 1.08
Adam17-dependent shedding limits early neutrophil influx but does not alter early monocyte recruitment to inflammatory sites. Blood (2011) 1.03
The absence of platelet-derived growth factor-B in circulating cells promotes immune and inflammatory responses in atherosclerosis-prone ApoE-/- mice. Am J Pathol (2005) 0.99
Intravital FLIM-FRET imaging reveals dasatinib-induced spatial control of src in pancreatic cancer. Cancer Res (2013) 0.99
Evidence that lipopolysaccharide-induced anorexia depends upon central, rather than peripheral, inflammatory signals. Endocrinology (2007) 0.99
Macrophage ADAM17 deficiency augments CD36-dependent apoptotic cell uptake and the linked anti-inflammatory phenotype. Circ Res (2013) 0.93
Metalloproteinase-mediated Shedding of Integrin β2 promotes macrophage efflux from inflammatory sites. J Biol Chem (2011) 0.93
A Lactobacillus rhamnosus GG-derived soluble protein, p40, stimulates ligand release from intestinal epithelial cells to transactivate epidermal growth factor receptor. J Biol Chem (2013) 0.92
Osteopontin mediates macrophage chemotaxis via α4 and α9 integrins and survival via the α4 integrin. J Cell Biochem (2013) 0.90
Endothelial deletion of ADAM17 in mice results in defective remodeling of the semilunar valves and cardiac dysfunction in adults. Mech Dev (2013) 0.90
An NF-kappaB-dependent transcriptional program is required for collagen remodeling by human smooth muscle cells. J Biol Chem (2003) 0.89
ADAM15 is an adherens junction molecule whose surface expression can be driven by VE-cadherin. Exp Cell Res (2002) 0.88
Development and bioorthogonal activation of palladium-labile prodrugs of gemcitabine. J Med Chem (2014) 0.88
Evolution of organelle-associated protein profiling. J Proteomics (2008) 0.87
Monocyte ADAM17 promotes diapedesis during transendothelial migration: identification of steps and substrates targeted by metalloproteinases. J Immunol (2013) 0.87
Dasatinib inhibits mammary tumour development in a genetically engineered mouse model. J Pathol (2013) 0.86
Are suppressors of cytokine signaling proteins recently identified in atherosclerosis possible therapeutic targets? Trends Cardiovasc Med (2005) 0.85
FLIM-FRET imaging in vivo reveals 3D-environment spatially regulates RhoGTPase activity during cancer cell invasion. Small GTPases (2011) 0.84
Beyond the endothelium: NF-kappaB regulation of smooth muscle function. Circ Res (2004) 0.83
Inhibition of NF-κB signaling ablates the invasive phenotype of glioblastoma. Mol Cancer Res (2013) 0.83
History of discovery: platelet-derived growth factor. Arterioscler Thromb Vasc Biol (2011) 0.82
Simvastatin reduces MMP1 expression in human smooth muscle cells cultured on polymerized collagen by inhibiting Rac1 activation. Arterioscler Thromb Vasc Biol (2007) 0.81
Gain and loss of function for glutathione synthesis: impact on advanced atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2011) 0.80
Advances in retroviral transduction of hematopoietic stem cells for the gene therapy of atherosclerosis. Curr Opin Lipidol (2003) 0.80
Emerging roles of TACE as a key protease in ErbB ligand shedding. Mol Interv (2002) 0.79
Live cell in vitro and in vivo imaging applications: accelerating drug discovery. Pharmaceutics (2011) 0.79
Cleavage of focal adhesion kinase in vascular smooth muscle cells overexpressing membrane-type matrix metalloproteinases. Arterioscler Thromb Vasc Biol (2004) 0.79
Hematopoietic Fas deficiency does not affect experimental atherosclerotic lesion formation despite inducing a proatherogenic state. Am J Pathol (2011) 0.78
Bcl-2 overexpression leads to increases in suppressor of cytokine signaling-3 expression in B cells and de novo follicular lymphoma. Mol Cancer Res (2004) 0.78
Antigen-independent targeting of long-lived CD4+ cytolytic T effector cells to lesions of atherosclerosis. Circ Res (2006) 0.78
Advanced intravital subcellular imaging reveals vital three-dimensional signalling events driving cancer cell behaviour and drug responses in live tissue. FEBS J (2013) 0.77
High-content analysis to leverage a robust phenotypic profiling approach to vascular modulation. J Biomol Screen (2013) 0.76
Integrin alpha(7)beta(1) COMPels smooth muscle cells to maintain their quiescence. Circ Res (2010) 0.75
Rapid Discovery and Structure-Activity Relationships of Pyrazolopyrimidines That Potently Suppress Breast Cancer Cell Growth via SRC Kinase Inhibition with Exceptional Selectivity over ABL Kinase. J Med Chem (2016) 0.75
Nogo puts the brake on vascular lesions. Nat Med (2004) 0.75
Novel ex vivo culture method for human monocytes uses shear flow to prevent total loss of transendothelial diapedesis function. J Leukoc Biol (2013) 0.75
Empirical drug discovery: a view from the proteome. Drug Discov Today Technol (2017) 0.75